The business world has been significantly disrupted by the pandemic. During situations of macro disruption, most people look for ways to first survive and eventually emerge from the circumstances stronger and better. As they do this, most leaders attempt to re-create past success—to go back to what life and business were like pre-disruption.
Few people look forward with excitement to the unpredictable, unknown future while living through the dissonance caused by ongoing disruptions. Yet because of what we have collectively experienced, there is no going back to the old state of things. Business environments are changing constantly. True business recovery is forward moving, embracing today’s reality and finding ways to thrive within it. The best measure of successful negotiation of disruption is how strongly you recover.
There are plenty of approaches to business recovery, but the key to success is avoiding the obstacles
“It is more important to know what kind of patient the disease has than to know what kind of disease the patient has.”
Although Hippocrates made this keen observation more than 2,400 years ago, physicians did not have the tools to decipher the biological and environmental factors influencing an individual’s health and well-being until recently.
Since the human genome was finally mapped in 2003, scientists have made tremendous progress in advancing personalized medicine. By tailoring health care to an individual’s biological characteristics, circumstances, and values, personalized medicine can bring unprecedented benefits to patients with rare genetic disorders, cancer, and other diseases.
The widely variable effects of the novel coronavirus serve as a painful reminder of the importance of understanding how and why people respond differently to the same disease.
But two recent moves by the Trump administration threaten to turn back the clock on biomedical progress in personalized